Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Hande

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Oncology|January 1, 1992
Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancerF A Greco, P B Murphy, J D Hainsworth, et al.
Renal Failure|March 1, 1995
Protection from cisplatin nephrotoxicity by A68828, an atrial natriuretic peptideP M Deegan, M P Ryan, M A Basinger, et al.
The New England Journal of Medicine|September 22, 1977
Use of plasma pharmacokinetics to predict and prevent methotrexate toxicityR G Stoller, K R Hande, S A Jacobs, et al.
Cancer Research|July 1, 1990
Kinetics of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641) in humansK R Hande, J Kuttesch, M Hamilton, et al.
Obstetrics and Gynecology|August 1, 1981
Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operationF A Greco, C G Julian, R L Richardson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbitsN L Harris, D E Brenner, L B Anthony, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Etoposide kinetics in patients with obstructive jaundiceK R Hande, S N Wolff, F A Greco, et al.
Cancer Research|June 15, 1987
Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbitD E Brenner, L B Anthony, S Halter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trialT M Waits, D H Johnson, J D Hainsworth, et al.
Renal Failure|November 1, 1995
The role of the renin-angiotensin system in cisplatin nephrotoxicityP M Deegan, C Nolan, M P Ryan, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Oncology|January 1, 1992
Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancerF A Greco, P B Murphy, J D Hainsworth, et al.
Renal Failure|March 1, 1995
Protection from cisplatin nephrotoxicity by A68828, an atrial natriuretic peptideP M Deegan, M P Ryan, M A Basinger, et al.
The New England Journal of Medicine|September 22, 1977
Use of plasma pharmacokinetics to predict and prevent methotrexate toxicityR G Stoller, K R Hande, S A Jacobs, et al.
Cancer Research|July 1, 1990
Kinetics of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641) in humansK R Hande, J Kuttesch, M Hamilton, et al.
Obstetrics and Gynecology|August 1, 1981
Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operationF A Greco, C G Julian, R L Richardson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbitsN L Harris, D E Brenner, L B Anthony, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Etoposide kinetics in patients with obstructive jaundiceK R Hande, S N Wolff, F A Greco, et al.
Cancer Research|June 15, 1987
Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbitD E Brenner, L B Anthony, S Halter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trialT M Waits, D H Johnson, J D Hainsworth, et al.
Renal Failure|November 1, 1995
The role of the renin-angiotensin system in cisplatin nephrotoxicityP M Deegan, C Nolan, M P Ryan, et al.
Pageof 11